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Thirteen asymptomatic women with postpartum blood loss of at least 500 cc were evaluated for anterior
pituitary endocrine function. Insulin tolerance tests and TRH stimulation tests were done and determinations
made for serum growth hormone, cortisol, thyrotropin, and prolactin. There was no laboratory evidence of
pituitary dysfunction in this group of 13 patients. Subclinical hypopituitarism in women with previous
postpartum hemorrhage would appear to be uncommon.
Spontaneous anterior pituitary insufficiency occurs most commonly in women
who have hemorrhaged during the postpartum period (Sheehan's Syndrome) [1].
Sheehan's Syndrome becomes clinically apparent in the puerperium with failure of
lactation followed by absent or scanty menses, loss of pubic and axillary hair,
atrophy of breasts and-genitals, pallor, infertility, and signs of adrenal and thyroid
insufficiency. However, Sheehan's Syndrome often emerges insidiously and may not
fully develop for several years [2]. Patients with long-standing Sheehan's Syndrome
are exposed to considerable risk especially during times of stress [3]. Since the onset
of clinically apparent disease may be delayed for several years, there may be a
number of apparently normal women who have experienced postpartum blood loss
and who may have impaired pituitary function. With increasing refinements in the
testing of pituitary function it might be possible to identify these women before they
develop clinical hypopituitarism. Anterior pituitary function was evaluated in
thirteen asymptomatic women who had postpartum hemorrhage.
METHODS AND PROCEDURES
Patient Selection
All patients at the Yale-New Haven Hospital with a discharge diagnosis of
postpartum hemorrhage within the past ten years were identified through chart
review of the medical records. Postpartum hemorrhage was defined as a minimum
estimated blood loss of 500 cc for purposes of the study. One hundred and forty
patients were identified; only 38 of these patients could be contacted by letter or
telephone call. After obtaining their obstetricians' consent, each patient was con-
tacted and their participation was solicited. Four patients were excluded from the
study because of pregnancy (two patients) and breastfeeding (two patients). Twelve
patients from the initial group of 38 agreed to participate. Three of these patients
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were taking estrogens: Orthonovum 1/80 R for contraception (two patients) and
Premarin R 1.25 mg as replacement therapy (one patient status-post bilateral oopho-
rectomy). These three patients will be discussed separately. A thirteenth patient
volunteered to participate, met the criteria for inclusion in the study, and was
accepted. Patients were not selected according to age, parity, obstetrical or medical
history, amount of estimated blood loss in excess of 500 cc, duration ofhemorrhage,
presence of hypotension or shock, or obstetrical cause of hemorrhage. The thirteen
patients ranged in agefrom 23 to 40 years with an estimated postpartum blood loss of
500 to 2000 cc (mean 1000 cc ± 130 cc{ ± SEM)) occurringfrom 1 to 10 years prior to
the initiation of this study. The nature of the study was discussed in detail with each
patient and all subjects gave informed written consent. This research was approved
by the Human Investigation Committee of the Yale-New Haven Hospital.
Protocol
All patients had a routine medical history and physical examination, formal fields
of vision examination (Goldmann perimetry), x-ray examination of the sella turcica,
24 hour urine collection for 17-hydroxycorticosteroids (170HCS) and 17-ketosteroids
(17KS), and determinations offasting blood glucose, 8 AM and 8 PM serum cortisols,
8 AM serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and
thyroid function tests. All patients underwent an insulin tolerance test with 0.1 units
of regular insulin/kg body weight injected IV over 30 seconds. Two patients required
0.15 units of regular insulin/kg body weight to obtain an adequate level of hypogly-
cemia. Serum samples were obtained at 30 minute intervals for glucose, cortisol,
growth hormone, and prolactin for two hours. All patients had a fall in blood glucose
of greater than 50 percent to levels below 40 mg/dl with a mean minimal glucose of
27 mg/dl.
All patients underwent a thyrotropin-releasing hormone (TRH) stimulation test
with 100 micrograms of TRH injected IV over 30 seconds. Serum samples were
obtained at 15 minute intervals for prolactin and thyrotropin over two hours. One
patient who failed to have a cortisol response to insulin hypoglycemia underwent a
metapyrone test and an ACTH stimulation test. Metapyrone 750 mgs q4h was given
orally for 24 hours. Twenty-four hour urine samples for 17-OHCS, 17-KS, and
compound S were obtained the day before, the day of, and the day after metapyrone
administration. An ACTH test was performed with IV Cortrosyn R 0.5 mg infused
over 8 hours from 9 AM to 5 PM. Twenty-four hour urine collections for 17-OHCS,
17-KS, and compound S as well as serum cortisols at 8 AM, 4 PM, and 6 PM were
obtained.
Assays
Radioimmunoassay determination of serum growth hormone, prolactin, and TSH
were performed according to standard procedures. Antisera for prolactin was
provided by the National Institutes of Health. Serum LH and FSH assays were
performed by Bio-Science Laboratories.
RESULTS
All patients except one had unremarkable medical histories and physical examina-
tions; one patient had idiopathic galactorrhea. There were no abnormal sella turcicas
by x-ray or abnormal fields ofvision by Goldmann perimetry. Serum determinations
of thyroxine, thyroxine binding capacity, estimated free thyroxine, 8 AM and 8 PM
serum cortisol, fasting blood glucose levels, and basal serum FSH and LH levels were
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all within normal limits. All patients had normal 24 hour urine collections of 17-
OHCS and 17-KS except for the one patient with idiopathic galactorrhea who had a
low 17-OHCS value.
Figures 1 through 5 show the individual cortisol, growth hormone, and prolactin
responses to insulin hypoglycemia and the TSH and prolactin responses to TRH
stimulation for the ten patients not receiving estrogens. Each figure also compares the
mean peak responses for these ten patients with the mean peak responses for normal
patients obtained from previous reports [4-12]. Mean peak responses derived from
these reports represent the grand mean and the standard error of the grand mean
obtained from a series of normal control groups not taking estrogens.
For the ten patients not receiving estrogens, insulin hypoglycemia resulted in a
mean peak cortisol of30.1 ± 2.2Mug/ml(Fig. 1), while the mean peak growth hormone
after insulin was 41.1 + 6.6Mg/ml (Fig. 2), and the mean peak prolactin was 25 ± 4.4
ng/ml (Fig. 3). TRH stimulation produced a mean peak TSH of 16.1 + 2.7MU/ml
(Fig. 4) and a mean peak prolactin of 28.1 ± 4.4 ng/ml (Fig. 5).
For the three patients receiving estrogens, insulin hypoglycemia produced a mean
peak cortisol of 58 ± 5.3,ug/ml, a mean peak growth hormone of53 ± 14.6.g/ml, and
a mean peak prolactin of 35.3 + 7.7 ng/ml; TRH stimulation produced a mean peak
TSH of 15.7 ± 9.2 MU/ml and a mean peak prolactin of 23 ± 3.8 ng/ml. Only the
cortisol value was significantly higher than in the patients not receiving estrogens
(P< .0001).
The patient with galactorrhea had a baseline 24 hour urine 17-OHCS of 2.3
mg/total volume and a subnormal cortisol response to insulin hypoglycemia (14
Mgldl). This patient was a 23 year old black female gravida two para two whose
second delivery was complicated by a post partum hemorrhage with an estimated
blood loss of 1000 cc. The patient did not elect to breastfeed either child. Normal
menses resumed after the second pregnancy, and the patient took oral contraceptives
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FIG. 1. Cortisol response to insulin hypoglycemia. Baseline and peak responses for individual patients (10) not
receiving estrogens. Comparison of mean peak responses for patients not receiving estrogens and for normal patients
reported in the literature.
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FIG. 2. Growth hormone response to insulin hypoglycemia. Baseline and peak responses for individual patients (10)
not receiving estrogens. Comparison of mean peak responses for patients not receiving estrogens and for normal patients
reported in the literature.
from 1969 to 1970. Galactorrhea began in early 1973. She denied menstrual
irregularity, physical stimulation, or the use of any medications. Physical examina-
tion revealed moderate obesity and galactorrhea but was otherwise unremarkable.
Her baseline serum prolactin was 12 ng/ml and rose to a peak of 28 ng/ml after
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FIG. 3. Prolactin response to insulin hypoglycemia. Baseline and peak responses for individual patients (10) not
receiving estrogens. Comparison of mean peak responses for patients not receiving estrogens and for normal patients
reported in the literature.
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FIG. 4. Thyrotropin response in TRH. Baseline and peak responses for individual patients (10) not receiving
estrogens. Comparison of mean peak responses for patients not receiving estrogens and for normal patients reported in
the literature.
TRH. Skull films and fields of vision by Goldmann perimetry were normal. All the
tests of endocrine function performed inthis study were normal with the exception of
her cortisol response to insulin hypoglycemia and her subnormal 24 hour 17-OHCS
excretion. Her pituitary-adrenal axis was further evaluated with a metapyrone test
and an ACTH test which were both normal. The cause ofher galactorrhea could not
be determined.
No evidence of anterior pituitary insufficiency was observed in these thirteen
patients.
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FIG. 5. Prolactin response to TRH. Baseline and peak responses for individual patients (10) not receiving estrogens.
Comparison of mean peak responses for patients not receiving estrogens and for normal patients reported in the
literature.
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DISCUSSION
Sheehan's Syndrome is the major cause of spontaneous anterior pituitary insuffi-
ciency [1]. This clinical entity is often overlooked and exposes the patient to
considerable risk particularly during periods of stress. Since the onset of clinically
apparent disease is often delayed for several years, there could be a significant
number of asymptomatic women who have had postpartum- hemorrhages with some
impairment of pituitary function. As Sheehan's Syndrome can be readily treated with
hormonal replacement therapy, it would be important to know the prevalence among
asymptomatic patients with previous postpartum hemorrhage oflaboratory evidence
of anterior pituitary insufficiency and to identify these patients before they develop
overt clinical disease.
Sheehan's Syndrome is typified by failure of lactation in the postpartum period,
scant or absent menses, loss of axillary and pubic hair, atrophy of the breasts and
genitals, pallor, cold intolerance, lethargy and hypersomnolence, slow monotonous
speech, apathy, infertility, deep hoarse voice, thick coarse or waxy skin, macroglos-
sia, generalized body hair loss, decreased libido, and chronic constipation. Although
severe pituitary necrosis usually causes total loss of anterior pituitary function,
isolated or partial deficiencies of pituitary hormones may occur [2], and there is no
definite sequence of loss of hormone function [13]. There have been numerous
reports of patients with Sheehan's Syndrome having normal pregnancies and
deliveries [2].
There is no general agreement about the pathogenesis ofSheehan's Syndrome. The
special vulnerability to ischemia of the pituitary gland during pregnancy is probably
related to the two to three-fold increase in size of the adenohypophysis during
pregnancy, as it is rare for reduced blood flow to cause pituitary necrosis in the non-
pregnant female. Indeed, reversible physiologic bitemporal hemianopsia can occur
secondary to pituitary enlargement [14]. Sheehan contends that necrosis is produced
by local ischemia due to vasospasm in the arterial supply. This results from any
severe circulatory collapse at the time of delivery, most commonly due to obstetrical
hemorrhage [15]. However, Kopaniky and Cann have found in dogs that as
hemorrhage increases, pituitary blood flow falls initially but then increases to levels
greater than control [16]. Gotshalk and Tilden have emphasized the importance of
the physiologic increase in pituitary size during pregnancy and have noted that a
massively enlarged gland confined within the limited volume ofthe rigid sella turcica
would be exposed to considerable pressure and would suffer some degree ofvascular
compression. In this setting, a sudden drop in blood pressure due to postpartum
hemorrhage might allow the increased tissue pressure to cause collapse of the
pituitary vasculature and ischemic necrosis. Gotshalk and Tilden described a patient
who was found to have a segment of the anterior lobe of the pituitary protruding
from the sella at autopsy; no necrosis was found in this area consistent with their
hypothesis [17]. Meador and Worrell reported three patients with Sheehan's Syn-
drome in whom the sella turcica was significantly smaller than in normal controls
[18]. An abnormally small sella turcica would further compress the physiologically
enlarged gland and might predispose a patient with depleted blood volume to
irreversible ischemia and anterior pituitary necrosis.
The three patients receiving estrogens were presented separately because of the
known effect ofestrogens on some tests ofendocrinefunction. Estrogens elevate total
serum cortisol and total serum thyroxine values by increasing transcortin and
thyroxine-binding globulin levels. Ramey et al. have shown that oral contraceptives
caused a significant increase in TSH response to TRH in normal euthyroid females
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[5]. Carlson et al. have shown that estrogens augment the prolactin response to TRH
[19]. There are no reports in the medical literature on the effect of estrogens on
cortisol, growth hormone, or prolactin response to insulin hypoglycemia. In the
present study estrogens caused a significant increase in mean peak cortisol response
to insulin hypoglycemia (P< .0001, paired "t" test). The mean peak cortisol response
for patients receiving estrogens was 58.0Ag/ml in contrast to a mean peak cortisol
response of 30.1 mg/ml for patients not receiving estrogens. This effect of estrogens
on cortisol response was not expected and has not been observed previously.
Estrogens had no significant effect on prolactin response to TRH or on growth
hormone or prolactin response to insulin hypoglycemia. Patients receiving estrogens
did not have an increased TSH response to TRH as compared to patients not on
estrogens. However, the patients were not tested before receiving estrogens and did
not serve as their own controls [5].
All thirteen patients had significant increases in prolactin levels when stimulated
with TRH. In contrast, four patients did not have significant increases in prolactin
levels when stimulated by insulin hypoglycemia. The mean prolactin baseline value
for all thirteen patients was 9.7 ± 1.0 ng/ml (± SEM) in the TRH test and 27.4 ± 3.9
ng/ml (± SEM) in the insulin tolerance test. Both tests appear to be useful in
evaluating prolactin secretion and yield remarkably similar results. However, not all
patients in the study responded to insulin hypoglycemia. The prolactin response to
insulin hypoglycemia has been shown to be a sensitive index of pituitary function
[20], and it may be prudent to perform both tests.
The mean blood loss in these patients was estimated to be 1000 cc and it might be
argued that this degree of blood loss was too small to cause hypopituitarism.
However, there appears to be no correlation between the amount of blood loss and
the subsequent development ofanterior pituitary insufficiency[2,21]. Effkemann and
Muller-Jager found that in a group of 84 patients who lost between 800 and 1600 cc
of blood at the time ofdelivery, 12 ofthe 20 patients who lost between 1200 and 1600
cc of blood suffered decreased menstrual function and 10 ofthese 20 patients became
permanently sterile [22].
In a survey of 128 females with postpartum hemorrhage, 41 women (32%) had
some degree ofdiminished pituitary function [23]. Thus, out of this current group of
13 women with postpartum hemorrhage, 4 womenmight have been expected to show
diminished pituitary function. Previous studies of pituitary function were done with
relatively crude measures of hormone function. The availability of hypothalamic
releasing hormones and protein hormone determinations has greatly increased the
ability to study pituitary function. However, the small number of patients studied
precludes any firm conclusions about theincidence ofsubclinical pituitary hypofunc-
tion or the predictive value of the pituitary function tests.
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